检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:黄克斌[1] 徐樊[2] 张亚萍[3] 王景昌[4] 赵明利[3] 叶明[5]
机构地区:[1]解放军第三医院同位素科,陕西宝鸡721004 [2]解放军第三医院理疗科,陕西宝鸡721004 [3]解放军第三医院内分泌科,陕西宝鸡721004 [4]解放军第三医院血液科,陕西宝鸡721004 [5]解放军第三医院检验科,陕西宝鸡721004
出 处:《标记免疫分析与临床》2012年第4期224-225,共2页Labeled Immunoassays and Clinical Medicine
摘 要:目的探讨131I治疗甲状腺功能亢进(甲亢)的临床疗效。方法对126例甲亢患者给予131I治疗,并对其疗效进行分析。结果治疗的126例甲亢中,117例痊愈,治愈率92.9%,1年后发生甲减9例,甲减发生率7.1%。结论131I治疗甲亢是一种安全、有效的方法。Objective To explore the curative effect of 131I in the treatment of hyperthyroidism.Method 126 patients with hyperthyroidism were treated with 131I and the curative effect was analyzed.Result The results showed that among 126 cases of hyperthyroidism treated with 131I,117 cases had recovered and the cure rate was 92.9%.9 cases were found hypothyroidism in one-year follow-up and the occurrence rate was 7.1%.Conclusion The treatment of hyperthyroidism with 131I is safe and effective method.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145